CD4+ T‐cell‐mediated anti‐tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Immunology

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.200839152PMID 19338001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.

  2008cited by this paper
• Induction and effector functions of TH17 cells

  2008cited by this paper
• How microorganisms tip the balance between interleukin-12 family members

  2008cited by this paper
• Tumor-specific Th17-polarized cells eradicate large established melanoma.

  2008cited by this paper
• Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitope.

  2007cited by this paper
• Differentiation and function of Th17 T cells.

  2007cited by this paper
• Stat3 and Stat4 Direct Development of IL-17-Secreting Th Cells1

  2007cited by this paper
• Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression

  2006cited by this paper
• Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread.

  2005cited by this paper
• CD4 cells can be more efficient at tumor rejection than CD8 cells.

  2005cited by this paper
• Peripheral Blood CD4+ T-Cell Response Before Postoperative Active Immunotherapy Correlates with Clinical Outcome in Metastatic Melanoma

  2004cited by this paper
• GADD45beta/GADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNgamma production in T cells.

  2004cited by this paper
• CTL-Dependent and -Independent Antitumor Immunity Is Determined by the Tumor Not the Vaccine1

  2004cited by this paper
• GADD45β/GADD45γ and MEKK4 comprise a genetic pathway mediating STAT4‐independent IFNγ production in T cells

  2004cited by this paper
• STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation.

  2004cited by this paper
• Vaccination-Induced Autoimmune Vitiligo Is a Consequence of Secondary Trauma to the Skin

  2004cited by this paper
• CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame

  2003cited by this paper
• Immunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells

  2003cited by this paper
• Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.

  2001cited by this paper
• The role of STAT6 in mast cell IL‐4 production

  2001cited by this paper
• Signal Transducer and Activator of Transcription 6 Controls Chemokine Production and T Helper Cell Type 2 Cell Trafficking in Allergic Pulmonary Inflammation

  2001cited by this paper
• The risk of autoimmunity associated with tumor immunotherapy

  2001cited by this paper
• Identification of STAT4-Dependent and Independent Mechanisms of Resistance to Toxoplasma gondii1

  2000cited by this paper
• CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

  2000cited by this paper
• Coupling and Uncoupling of Tumor Immunity and Autoimmunity

  1999cited by this paper
• Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

  1999cited by this paper
• CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ

  1999cited by this paper
• CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.

  1999cited by this paper
• Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway.

  1999cited by this paper
• A Signal Transducer and Activator of  Transcription (Stat)4-independent Pathway for the Development of  T Helper Type 1 Cells

  1998cited by this paper
• Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma.

  1998cited by this paper
• Inhibition of Angiogenesis by Interleukin 4

  1998cited by this paper
• The Central Role of CD4+ T Cells in the Antitumor Immune Response

  1998cited by this paper
• Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1.

  1997cited by this paper
• Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice

  1996cited by this paper
• Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene

  1996cited by this paper

• Bacterial hitchhiking with drug-loaded nanoparticles as a drug delivery strategy for cancer immunotherapy

  2025cites this paper
• A Filippov tumor-immune system with antigenicity

  2023cites this paper
• Exploring the Interactions of Oncolytic Viral Therapy and Immunotherapy of Anti-CTLA-4 for Malignant Melanoma Mice Model

  2023cites this paper
• CD8+ T cell self-tolerance permits responsiveness but limits tissue damage

  2021cites this paper
• Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T‐cell protective responses to breast cancer

  2021cites this paper
• Mathematical Modelling for the Role of CD4+T Cells in Tumor-Immune Interactions

  2020cites this paper
• A mathematical model of tumor-immune interactions with an immune checkpoint inhibitor

  2019cites this paper
• Classification of triple-negative breast cancers based on Immunogenomic profiling

  2018cites this paper
• Dynamics of tumor-CD4-cytokine-host cells interactions with treatments

  2018cites this paper
• Optimal Treatments in Cancer Immunotherapy Involving CD4+ T Cells

  2018cites this paper
• Vaccination efficacy with marrow mesenchymal stem cell against cancer was enhanced under simulated microgravity.

  2017cites this paper
• IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils

  2017cites this paper
• Periodically Pulsed Immunotherapy in a Mathematical Model of Tumor, CD4+ T Cells, and Antitumor Cytokine Interactions

  2017cites this paper
• Correlation between circulating tumor cells EGFR expression and T cell subsets in advanced non-small cell lung cancer patients after tyrosine kinase inhibitor treatment.

  2017cites this paper
• Contribution of complement anaphylatoxin receptors to melanoma growth: potential therapeutic targets

  2016cites this paper
• Silencing of stat4 gene inhibits cell proliferation and invasion of colorectal cancer cells.

  2015cites this paper
• Qualitative behavior of systems of tumor–CD4+–cytokine interactions with treatments

  2015cites this paper
• Activation of cellular immunity and marked inhibition of liver cancer in a mouse model following gene therapy and tumor expression of GM-SCF, IL-21, and Rae-1

  2013cites this paper
• The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese

  2013cites this paper
• Functional Tumor Infiltrating TH1 and TH2 Effectors in Large Early-Stage Cervical Cancer Are Suppressed by Regulatory T Cells

  2012cites this paper
• Targeting Th (Th17 and Th2) suppressive and stimulatory effect on cytotoxic T cells

  2012cites this paper
• Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity

  2011cites this paper
• CD4 T cell dependent tumor immunity stimulated by dendritic cell based vaccine.

  2011cites this paper
• Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models

  2011cites this paper
• Autoimmunity and treatment outcome in melanoma

  2011cites this paper
• Combining Cancer Vaccines with Conventional Therapies

  2011cites this paper
• The utilization of activated B cell for cell carrier for viral vectored antigen delivery in the acceleration of CD8 T cell recall response

  2011cites this paper
• Immunologic functions as prognostic indicators in melanoma

  2011cites this paper
• Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4*

  2010cites this paper
• Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma.

  2010influential citation
• Processing of tumor antigen differentially impacts the development of helper and effector CD4+ T-cell responses.

  2010cites this paper